JDVVX
Price
$26.19
Change
-$0.21 (-0.80%)
Updated
Dec 17 closing price
RMFCX
Price
$55.64
Change
-$3.00 (-5.12%)
Updated
Dec 17 closing price
Ad is loading...

JDVVX vs RMFCX

Header iconJDVVX vs RMFCX Comparison
Open Charts JDVVX vs RMFCXBanner chart's image
JHancock Disciplined Value R5
Price$26.19
Change-$0.21 (-0.80%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$55.64
Change-$3.00 (-5.12%)
VolumeN/A
CapitalizationN/A
JDVVX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JDVVX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDVVX is a Buy and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 104B vs. JDVVX (15.6B). RMFCX pays higher dividends than JDVVX: RMFCX (1.69) vs JDVVX (0.97). JDVVX was incepted earlier than RMFCX: JDVVX (16 years) vs RMFCX (23 years). JDVVX is a more actively managed with annual turnover of: 43.00 vs. RMFCX (25.00). JDVVX has a lower initial minimum investment than RMFCX: JDVVX (0) vs RMFCX (250). RMFCX (12.63) and JDVVX (12.62) have marching annual gain over last year. RMFCX return over 5 years is better than : 40.39 vs. JDVVX (29.58).
JDVVXRMFCXJDVVX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years23 years-
Gain YTD17.81411.423156%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets15.6B104B15%
Annual Yield % from dividends0.971.6958%
Returns for 1 year12.6212.63100%
Returns for 3 years16.4914.16116%
Returns for 5 years29.5840.3973%
Returns for 10 years45.8861.8474%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc